Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    1%
    Check dated 2024-10-03T05:06:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.
    Difference
    2%
    Check dated 2024-09-25T22:41:18.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    1.0%
    Check dated 2024-09-18T16:45:31.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Results have been submitted, replacing the previous status of no results posted.
    Difference
    0.1%
    Check dated 2024-09-11T07:56:00.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.7%
    Check dated 2024-09-04T04:58:46.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-08-21T00:39:26.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.